Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review AAM Nawfal M. Sheaheed, Hayder K. Hassoun Neurological Research, 2021 | 17* | 2021 |
Assessment of cognitive functions in patients with multiple sclerosis FBH Nawfal M. Sheaheed, Tara Abdul-Qadir Al-Falaki Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021 | 8 | 2021 |
EEG Changes in Patients with Migraine Majeed Salih Hamad, Nawfal M. Sheaheed, Sarmed Mohammad Abdulrasool,Akram M ... The Iraqi Postgraduate Medical Journal 13 (2), 156-160, 2014 | 6* | 2014 |
CYP2D6 Genotype in relation to liver toxicity due to tetrabenazine in Iraqi patients with hyperkinetic movement disorders ZA Abbood, SH Ali, NM Sheaheed Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512 …, 2020 | 2 | 2020 |
Expert opinion on the pharmacological management of multiple sclerosis in women of childbearing age in Iraq HK Hassoun, A Almahdawi, SJ Al-Bajalan, NM Sheaheed, MAS Kamil, ... Heliyon 9 (2), 2023 | 1 | 2023 |
INVESTIGATION OF NEUROFILAMENT LIGHT CHAIN, VITAMIN D AND CALCIUM IN IRAQI PATIENTS WITH MULTIPLE SCLEROSIS. NN Alzaidi, KM Salih, NM Sheaheed Biochemical & Cellular Archives 21 (1), 2021 | 1 | 2021 |
Prognostic Value of Intracerebral Hemorrhage Score in Patients with Spontaneous Intracerebral Hemorrhage NMS Ali Karim, Jawad Ibrahim Rasheed, Karrar Hadi Hammoodi Iraq Medical Journal 3 (1), 17-22, 2019 | 1 | 2019 |
Nucleotide-binding and oligomerization domain-like receptor protein 3 inflammasome expression and activation in multiple sclerosis Haider F. Ghazi,Nawfal M. Sheaheed, Raghda A. Hussein Drug Invention Today 11 (3), 614-620, 2019 | 1 | 2019 |
HLA-DRB allels, IL-10 and Vitamin D level: Potential Impact on Multiple Sclerosis Ahmed A.H. Abbas, Alaa H. Khaliel, Nawfal M. Shaheed Iraqi JMS 14 (2), 159-165, 2016 | 1* | 2016 |
Iraqi experts consensus on the management of relapsing remitting multiple sclerosis in adults HK Hassoun, AO Hatem, A Al-Mahdawi, S Jamal Al-Bajalan, ... Current Medical Research and Opinion, 1-9, 2024 | | 2024 |
Oral Opportunistic Bacteria in Multiple Sclerosis with Different Treatment Modalities ZM Al-Saadi, FD Al-Aswad, NM Sheaheed Iranian Journal of War and Public Health 15 (2), 191-198, 2023 | | 2023 |
Assessment of Some Platelet Activating Markers and Secretory Status with Clinical Manifestations in Multiple Sclerosis Iraqi Patients KM Salih, AH Abdullah, NM Sheaheed Al-Mustansiriyah Journal of Science 33 (3), 12-19, 2022 | | 2022 |
Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review AA Nawfal M. Sheaheed Multiple Sclerosis and Related Disorders 59, doi:https//doi.org/10.1016/j.msard, 2022 | | 2022 |
Serum Neurofilament Light Chain: A Biomarker of Disease Activity and Progression in Multiple Sclerosis AMS Nawfal Madhi Sheaheed, Hassan Lafta Atiyah Indian Journal of Ecology 48 (18), 2021 | | 2021 |
Influence of hematological indices on disability score in Multiple sclerosis patients AHA Nawfal M. Sheaheed, Khalid Salih Indian Journal of Ecology 48 (18), 2021 | | 2021 |
NEFL gene Expression Analysis in a sample of Iraqi Multiple Sclerosis Patients HL ATIYAH, AM SAUD, NM SHEAHEED International Journal of Pharmaceutical Research 13 (1), 2021 | | 2021 |
Investigation of Neurofilament Light Chain , Vitamin D and Calcium in Iraqi Patients with Multiple Sclerosis KMS Nawfal Madhi Sheaheed, Najwan N Alzaidi Biochemical and Cellular Archives 21 (1), 2020 | | 2020 |
Evaluation of NEDA-3 in Relapsing Remitting Multiple Sclerosis Patients Treated with Fingolimod WMA Nawfal Madhi Sheaheed INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH 12 (3), 3654-3660, 2020 | | 2020 |
Treatment of Iraqi People with Hyperkinetic Movement Disorders by Tetrabenazine in Relation to Genetic Polymorphism of CYP450 2D6 ZA Abbood, SH Ali, NM Sheaheed Jinu. M, Thankamma. P. George, NA Balaram, Sujisha. SS 2. Profile of Burn …, 2020 | | 2020 |
Staphylococcus aureus enerotoxin A as a major risk factor for multiple sclerosis severity TRA Nawfal Madhi Sheaheed, Suhaib Khalid Ibrahim Journal of Global Pharma Technology 12 (suppl. No. 03), 2020 | | 2020 |